Ovarian neoplasm
- Synonyms
- Neoplasm of ovary; Ovarian Neoplasms; Ovarian tumor
Summary
Available tests
Check Related conditions for additional relevant tests.
Genes See tests for all associated and related genes
Also known as: AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA, AKT1
Summary: AKT serine/threonine kinase 1Also known as: Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM, UVO, CDH1
Summary: cadherin 1Also known as: CTNNB, EVR7, MRD19, NEDSDV, armadillo, CTNNB1
Summary: catenin beta 1Also known as: CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19, NEU, NGL, TKR1, VSCN2, c-ERB-2, c-ERB2, p185(erbB2), ERBB2
Summary: erb-b2 receptor tyrosine kinase 2Also known as: IGLON1, OBCAM, OPCM, OPCML
Summary: opioid binding protein/cell adhesion molecule likeAlso known as: CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha, PIK3CA
Summary: phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alphaAlso known as: AR-JP, LPRS2, PARK2, PDJ, PRKN
Summary: parkin RBR E3 ubiquitin protein ligase
- NCCN, 2024NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesĀ®), Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer, 2024
- NICE, 2023UK NICE Clinical guideline (CG122), Ovarian cancer: recognition and initial management, 2023
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.